DARBITOP 40mcg Injection 1's

Haemorrhoid Rx required
OUT OF STOCK

Best Price*  ₹ 2,440.00
MRP ₹3,050.00
(Inclusive of all taxes) *This product cannot be returned for a refund or exchange. * Mkt: Alniche Life Sciences Pvt Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout



INTRODUCTION

DARBITOP 40MCG contains Darbepoetin alfa which belongs to a class of medications called erythropoiesis-stimulating agents (ESAs). It is used to treat anemia. Anemia is a condition where your blood does not contain enough red blood cells and symptoms may be fatigue, weakness and shortness of breath. It works in the same way as erythropoietin, the natural hormone which is produced in your kidneys and encourages your bone marrow to produce more red blood cells.

Always use DARBITOP 40MCG as your doctor has told you. It is not recommended for the use in children and adolescents under 18 years. Do not take this medicine, if you have suffered from sickle cell anemia, epileptic fits (seizures) and convulsions (fits or seizures). It should be used with caution in pregnant or breastfeeding women. Consult your doctor before taking this medicine. Tell your doctor, if you are taking or taken or might take any other medicines. The most common side effects include stroke, pain around the area injected, rash and/or redness of the skin, allergic reactions, high blood pressure, blood clots (thrombosis) and fluid retention (oedema).

USES OF DARBITOP 40MCG

  • Treat Anemia

HOW DARBITOP 40MCG WORKS

It works by causing bone marrow (soft tissue inside the bones where blood is made) to make more red blood cells.

DIRECTIONS FOR USE

Always use DARBITOP 40MCG as your doctor has told you. Your injection to be given under the skin (subcutaneous).

SIDE EFFECTS OF DARBITOP 40MCG

COMMON

  • stroke
  • pain around the area injected
  • rash and/or redness of the skin
  • allergic reactions
  • high blood pressure
  • blood clots (thrombosis)
  • fluid retention (oedema)

HOW TO MANAGE SIDE EFFECTS

Skin rash:

Avoid bath in hot water because hot water can irritate the skin. Moisturizers can be used regular basis to soothe and hydrate the affected area.

WARNING & PRECAUTIONS

PREGNANCY

DARBITOP 40MCG should be used with caution in pregnant women. Consult your doctor before taking this medicine.

BREASTFEEDING

DARBITOP 40MCG is not recommended for use in breastfeeding women unless necessary. Discuss the risks and benefits with your doctor.

ALCOHOL

Consumption of alcohol is not recommended during treatment with DARBITOP 40MCG.

KIDNEY

DARBITOP 40MCG should be taken with caution in patients with severe kidney disease. Consult your doctor for advice.

LIVER

DARBITOP 40MCG should be taken with caution in patients with severe liver disease. Consult your doctor for advice.

ALLERGY

Do not take if you are allergic to the medicine.

HEART DISEASE

If you have any heart related problems, consult your doctor for advice before taking this medicine.

OTHERS

Do not take this medicine, if you have suffered from sickle cell anemia, epileptic fits (seizures) and convulsions (fits or seizures).

INTERACTIONS

Talk to your doctor if you are using, have recently used or might use any other medicines.

SYNOPSIS

Drug :   Darbepoetin alfa
Pharmacological Category :   Erythropoiesis-stimulating agents
Therapeutic Indication :   Anemia
Dosage Forms :   Injection

MORE INFORMATION

Store in a refrigerator (2-8°C). Do not freeze. Keep out of reach of children.

FAQs ABOUT DARBITOP 40MCG

Can DARBITOP 40MCG be used in pregnant women?

No. It should be used with caution in pregnant women. Consult your doctor before taking this medicine.

Is DARBITOP 40MCG a chemo drug?

It does not treat cancer. It is a support medication in treating anaemia associated with chronic kidney disease (CKD) caused by chemotherapy cancer treatment.

REFERENCES

1. Aleix Cases; Darbepoetin alfa: a novel erythropoiesis-stimulating protein; [Revised on Jul 2003] [Accessed 07 Jan 2021] https://pubmed.ncbi.nlm.nih.gov/12973399/

2. K.D.Tripathi, Essentials of medical pharmacology, DRUGS AFFECTING BLOOD AND BLOOD FORMATION, Chapter 43 – HAEMATINICS AND ERYTHROPOIETIN, 7th edition 2013, Page – 611.

3. Glenmark Pharmaceuticals s.r.o., Amgen; [Revised on Apr 2016] [Accessed 07 Jan 2021] https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/aranesp/ckd/aranesp_pi_hcp_english.pdf

4. Amgen Europe B.V.; Electronic Medicines Compendium (EMC); [Revised on Nov 2019] [Accessed 07 Jan 2021] https://www.medicines.org.uk/emc/files/pil.6958.pdf

PRODUCT DETAILS

    Net Qty
    1
    Item Weight
    20
    Ingredient
    DARBEPOETIN ALFA 40 MCG
    Hsn Code
    30049099
ALTERNATE BRANDS View All
Ibidarb 40mcg Injection 1'S
Prescription Haematopoiesis Rx required
Out of stock
Rs.1,736.10
Dargen 40mcg Injection(Pfs) 0.4ml
Prescription Haematopoiesis Rx required
Out of stock
Rs.2,280.00
Darberel 40mcg Injection 0.4ml
Prescription Blood Clot Rx required
Out of stock
Rs.2,467.50
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright© 2021. All Rights Reserved.